文献速递认知障碍与痴呆

阿尔茨海默病中APOE-ε4、骨关节炎与β-淀粉样蛋白及tau蛋白在初级运动与躯体感觉区积聚的关联

Association of APOE-ε4, Osteoarthritis, β-Amyloid, and Tau Accumulation in Primary Motor and Somatosensory Regions in Alzheimer Disease.
PubMed 文献 · Neurology · 2023-05-15

本研究纳入374例β-淀粉样蛋白阳性(Aβ+)的阿尔茨海默病神经影像学倡议受试者,基线18F-florbetapir PET确认Aβ阳性,中位随访3.3年。结果显示骨关节炎(OA)而非APOE-ε4与中央后回Aβ积累更快相关,OA与中央前回和中央后回随访时tau水平更高相关,OA与APOE-ε4交互关联tau沉积。

要点

  • OA而非APOE-ε4与中央后回Aβ积累更快相关(β=0.005)。
  • OA与中央前回和中央后回随访时tau水平更高相关。
  • OA与APOE-ε4交互关联中央前回和中央后回tau沉积更高。

核心结论

  • 本研究提示OA与初级运动区和躯体感觉区Aβ积累更快及Aβ依赖的未来tau沉积更高相关,为OA增加AD风险提供新见解。

研究设计与样本

  • 研究纳入374例Aβ+的阿尔茨海默病神经影像学倡议受试者,基线18F-florbetapir PET确认Aβ阳性,具有纵向Aβ PET、OA病史记录和APOE-ε4基因分型。

主要发现

  • OA和APOE-ε4均与中央前回和中央后回基线FBP SUVR无关。
  • 随访时OA而非APOE-ε4与中央后回Aβ积累更快相关(β=0.005,95%CI 0.001-0.008)。
  • OA而非APOE-ε4与中央前回随访时FTP tau水平更高相关(β=0.098,95%CI 0.034-0.162)。
  • OA而非APOE-ε4与中央后回随访时FTP tau水平更高相关(β=0.105,95%CI 0.040-0.169)。
  • OA与APOE-ε4交互关联中央前回(β=0.128,95%CI 0.030-0.226)和中央后回(β=0.124,95%CI 0.027-0.223)随访时FTP tau沉积更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: One of the most prevalent chronic diseases, osteoarthritis (OA), may work in conjunction with APOE-ε4 to accelerate Alzheimer disease (AD) alterations, particularly in the primary motor (precentral) and somatosensory (postcentral) cortices. To understand the reasoning behind this, we investigated how OA and APOE-ε4 influence the accumulation of β-amyloid (Aβ) and tau accumulation in primary motor and somatosensory regions in Aβ-positive (Aβ+) older individuals. METHODS: We selected Aβ+ Alzheimer Disease Neuroimaging Initiative participants, defined by baseline 18F-florbetapir (FBP) Aβ PET standardized uptake value ratio (SUVR) of AD summary cortical regions, who had longitudinal Aβ PET, the records of OA medical history, and APOE-ε4 genotyping. We examined how OA and APOE-ε4 relate to baseline and longitudinal Aβ accumulation and tau deposition measured at follow-up in precentral and postcentral cortical areas and how they modulate Aβ-associated future higher tau levels, adjusting for age, sex, and diagnosis and using multiple comparison corrections. RESULTS: A total of 374 individuals (mean age 75 years, 49.2% female, 62.8% APOE-ε4 carriers) who underwent longitudinal FBP PET with a median follow-up of 3.3 years (interquartile range [IQR] 3.4, range 1.6-9.4) were analyzed, and 96 people had 18F-flortaucipir (FTP) tau PET measured at a median of 5.4 (IQR 1.9, range 4.0-9.3) years postbaseline FBP PET. Neither OA nor APOE-ε4 was related to baseline FBP SUVR in precentral and postcentral regions. At follow-up, OA rather than APOE-ε4 was associated with faster Aβ accumulation in postcentral region (β = 0.005, 95% CI 0.001-0.008) over time. In addition, OA but not the APOE-ε4 allele was strongly linked to higher follow-up FTP tau levels in precentral (β = 0.098, 95% CI 0.034-0.162) and postcentral (β = 0.105, 95% CI 0.040-0.169) cortices. OA and APOE-ε4 were also interactively associated with higher follow-up FTP tau deposition in precentral (β = 0.128, 95% CI 0.030-0.226) and postcentral (β = 0.124, 95% CI 0.027-0.223) regions. DISCUSSION: This study suggests that OA was associated with faster Aβ accumulation and higher Aβ-dependent future tau deposition in primary motor and somatosensory regions, providing novel insights into how OA increases the risk of AD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Du J, Li A, Shi D, et al. Association of APOE-ε4, Osteoarthritis, β-Amyloid, and Tau Accumulation in Primary Motor and Somatosensory Regions in Alzheimer Disease. Neurology. 2023. PMID: 37188537. doi:10.1212/WNL.0000000000207369

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。